A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors

Clinical trial NCT00612209 · COMPLETED

Trial details

NCT number: NCT00612209
Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer, Advanced Solid Tumors

Start date: 2007-04-01
Primary completion: 2010-01-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.